Ajay Kirtane
Interventional Cardiology · New York, NYNPI 1780651497
Payments from drug & device makers
Across 540 payments — averaging $3390.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$555K
- Abbott$505K
- Boston Scientific$407K
- Recor Medical Inc$117K
- Philips North America LLC$65K
- Shockwave Medical, Inc$56K
- plus $126K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 128 | $555,068 |
| Abbott | 76 | $505,213 |
| Boston Scientific | 130 | $406,987 |
| Recor Medical Inc | 46 | $116,944 |
| Philips North America LLC | 5 | $64,626 |
| Shockwave Medical, Inc | 10 | $56,456 |
| Siemens Medical Solutions USA, Inc. | 4 | $40,697 |
| Chiesi USA, Inc. | 9 | $28,800 |
| Janssen Research & Development, LLC | 4 | $25,260 |
| Merck | 12 | $13,298 |
| Biotronik Inc. | 16 | $8,755 |
| Idorsia Pharmaceuticals US Inc | 8 | $2,460 |
| Cardiovascular Systems Inc. | 10 | $1,313 |
| Cathworks, Inc. | 7 | $1,083 |
| Edwards Lifesciences | 4 | $532 |
| Abiomed | 6 | $490 |
| Teleflex LLC | 3 | $470 |
| Novartis | 21 | $361 |
| Amgen | 9 | $312 |
| Neovasc Medical Inc | 3 | $305 |
| Acist Medical Systems, Inc. | 2 | $299 |
| Cordis US CORP. | 1 | $214 |
| Boehringer Ingelheim | 9 | $163 |
| Heartflow, Inc. | 6 | $136 |
| Regeneron | 1 | $130 |
| Asahi Intecc USA, Inc. | 3 | $111 |
| W. L. Gore & Associates, Inc. | 1 | $89 |
| Angiodynamics, Inc. | 1 | $87 |
| Pfizer | 1 | $38 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $37 |
| Bridgebio Pharma, Inc. | 1 | $23 |
How this compares
$1,830,796 in reported general payments places this provider in the 95th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in New York
- Martin LeonNew York$13.5M
- Susheel KodaliNew York$6M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
- Annapoorna KiniNew York$3.5M
- Sahil ParikhNew York$2.7M
- George DangasNew York$2.6M
- Prakash KrishnanNew York$2M
- Shing-Chiu WongNew York$1.5M
- Anvar BabaevNew York$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.